Emilio Bria

44PUBLICATIONS
186CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Liquid biopsiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jul 28, 2026
High Prevalence of Superficial Metastases Supports Percutaneous Ultrasound-Guided Biopsy for Diagnosis and Molecular Profiling of Advanced Lung Cancer: Results from a Prospective Cohort.

|Jun 12, 2026
Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).

|May 30, 2026
Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

|Apr 03, 2026
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale.

Marzia Del Re, Elvira Inglese, Emilio Bria

|Nov 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.

Sara Pilotto, Lorenzo Belluomini, Federico Monaca

|Sep 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.

Alessio Cortellini, Valentina Santo, Leonardo Brunetti

Pageof 8

Frequent Collaborators

5 joint publications

Emanuele Vita

5 joint publications

Lorenzo Belluomini

5 joint publications

Aldo Scarpa

5 joint publications

Sara Pilotto